Table 1.

Characteristics of survivors and healthy donors.

	HD	EBOV_S	P value
No. of participants	39	35	N/A
Median age (years)	25 [21–36]	30 [25–36]	0.2
Sex (male)	31 (80%)	19 (54%)	0.03
Median time from ETC discharge to inclusion (months)	N/A	23 [19–25]	N/A
EBOV RT-PCRa	N/A	Negative (100%)
Clinical eventsb
All symptoms	N/A	23 (66%)	N/A
Joint pain	N/A	13 (37%)	N/A
Fatigue	N/A	12 (34%)	N/A
Ocular disorders	N/A	6 (17%)	N/A
Headache	N/A	6 (17%)	N/A
Muscle pain	N/A	5 (14.3%)	N/A
Fever	N/A	4 (11.4%)	N/A
Abdominal pain	N/A	2 (5.7%)	N/A
Anorexia	N/A	1 (2.8%)	N/A

The differences between healthy donors (HDs) and survivors (EBOV_S) were evaluated in nonparametric Mann–Whitney U tests or χ² test. Median values ± IQR are shown. Source data are provided as a Source Data file.

^aBlood samples were taken from patients enrolled in the Postebogui cohort. Before PBMC and serum freezing, EBOV RT-PCR was performed on each sample to exclude the presence of EBOV in the blood.

^bSymptoms and findings on physical examination for the EBOV_S on inclusion in the Postebogui cohort.